Glucagon increases contractility in ventricle but not in atrium of the rat heart

European Journal of Pharmacology

Volumn 587, Issue 1-3, 2008, Pages 243-247

  Gonzalez Muñoz, Carmen ^a   Nieto Cerón, Susana ^b   Cabezas Herrera, Juan ^b   Hernández Cascales, Jesús ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Cardiac contractility; Cyclic nucleotide phosphodiesterase; Glucagon; Isoprenaline; Pertussis toxin; Rat heart

Indexed keywords

BETA ADRENERGIC RECEPTOR; GLUCAGON; GLUCAGON RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; PERTUSSIS TOXIN; PHOSPHODIESTERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; ELECTRICITY; ENZYME ACTIVITY; FEMALE; HEART ATRIUM CONTRACTION; HEART MUSCLE CONTRACTILITY; HEART RIGHT VENTRICLE; HEART VENTRICLE CONTRACTILITY; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DENSITY; WESTERN BLOTTING;

1-METHYL-3-ISOBUTYLXANTHINE; ACTINS; ANIMALS; BLOTTING, WESTERN; CARDIOTONIC AGENTS; ELECTRIC STIMULATION; FEMALE; GLUCAGON; HEART; HEART ATRIA; HEART VENTRICLES; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; PERTUSSIS TOXIN; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 44149123542     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.001     Document Type: Article

References (25)

1. Anousis N., Carvalho R.A., Zhao P., Malloy C.R., and Sherry A.D. Compartmentation of glycolysis and glycogenolysis in the perfused rat heart. N.M.R. Biomed. 17 (2004) 51-59
2. Antonaccio M.J., and Cavaliere T. A comparison of the effects of some inotropic and chronotropic agents on isolated atria from normotensive (NTR) and spontaneously hypertensive (SHR) rats. Arch. int. Pharmacodyn. 209 (1974) 273-282
3. Bender A.T., and Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev. 58 (2006) 488-520
4. Bian J.S., Zhang W.M., Pei J.M., and Wong T.M. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon κ-opiod receptor stimulation in the rat heart. J. Pharmacol. Exp. Ther. 292 (2000) 1065-1070
5. Bode D.C., Kanter J.R., and Brunton L.L. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue. Circ. Res. 68 (1991) 1070-1079
6. Brodde O.E., and Michel M.C. Adrenergic and muscarinic receptors in the human heart. Pharmacol. Rev. 51 (1999) 651-689
7. DeWitt C.R., and Waksmann J.C. Pharmacology, pathophysiology and management of calcium channel blocker and β-blocker toxicity. Toxicol. Rev. 23 (2004) 223-238
8. Furukawa Y., Saegusa K., Ogiwara Y., and Chiba S. Different effectiveness of glucagon on the pacemaker activity and contractility in intact dog hearts and in isolated perfused right atria. Jpn. Heart J. 27 (1986) 215-222
9. Horinouchi T., Morishima S., Tanaka T., Suzuki F., Tanaka Y., Koike K., and Maramatsu I. Pharmacological evaluation of plasma membrane β-adrenoceptors in rat hearts using the tissue segment binding method. Life Sci. 79 (2006) 941-948
10. Juan-Fita M.J., Vargas M.L., and Hernández J. The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium. Eur. J. Pharmacol. 512 (2005) 207-213
11. Juan-Fita M.J., Vargas M.L., Kaumann A.J., and Hernández J. Rolipram reduces the inotropic tachyphylaxix of glucagons in rat ventricular myocardium. Naunyn-Schmiedeberg's Arch. Pharmacol. 370 (2004) 324-329
12. 2-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both Gs and Gi. Circ. Res. 87 (2000) 705-709
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
14. London J.A., and Sena M.J. Pharmacologic support of the failing heart. Surg. Clin. N. Am. 86 (2006) 1503-1521
15. MacLeod K.M., Rodgers R.L., and McNeill J.H. Characterization of glucagon-induced changes in rate, contractility and cyclic AMP levels in isolated cardiac preparation on the rat and guinea pig. J. Pharmacol. Exp. Ther. 217 (1981) 798-804
16. Matsuda Y., Toma T., Ogawa H., Matsuzaki M., Katayama K., Fujii T., Yoshino F., Moritani K., Kumada T., and Kusukawa R. Importance of the left atrial function in patients with myocardial infarction. Circulation 67 (1983) 565-571
17. Myslivecek J., Novakova M., Palkovits M., Krizanova O., and Kvetnansky R. Distribution of mRNA and binding sites of adernoceptors and muscarinic receptors in the rat heart. Life Sci. 79 (2006) 112-120
18. Nicholson C.D., Challiss R.A.J., and Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. Sci. 12 (1991) 19-27
19. Nord H.J., Fontanes A.L., and Williams J.F. Treatment of congestive heart failure with glucagon. Ann. Intern. Med. 72 (1970) 649-653
20. Rochais F., Abi-Gerges A., Horner K., Lefevre F., Cooper D.M., Conti M., Fischmeister R., and Vandecasteel G. A specific pattern of phosphodiesterase controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes. Circ. Res. 98 (2006) 1081-1088
21. Sandirasegarane L., and Diamond J. Pertussis toxin-sensitive G protein but not NO/cGMP pathway mediates the negative inotropic effect of carbachol in adult rat cardiomyocytes. Pharmacology 70 (2004) 46-56
22. Shepherd G. Treatment of poisoning caused by β-adrenergic and calcium-channel blockers. Am. J. Health-Syst. Pharm. 63 (2006) 1828-1835
23. Stevenson L.W. Clinical use of inotropic therapy for heart failure: looking backward or forward?. Circulation 108 (2003) 367-372
24. White C.M. A review of potential cardiovascular uses of intravenous glucagon administration. J. Clin. Pharmacol. 39 (1999) 442-447
25. Xiao R.P., Avdonin P., Zhou Y.Y., Cheng H., Akhter S.A., Eschenhagen T., Lefkowitz R.J., Koch W.J., and Lakatta E.G. Coupling of beta-2 adrenoceptor to Gi protein and its physiological relevance in murine cardiac myocytes. Circ. Res. 84 (1999) 43-52